Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.
, as well as by the U.S. Chamber of Commerce and PhRMA, the pharmaceutical industry's largest lobbying group, made similar arguments.
J&J said its suit aims to stop the "innovation-damaging congressional overreach that threatens the United States' primacy in developing transformative therapies and in patients' access to those treatments." The policy aims to make drugs more affordable for older Americans but will likely reduce pharmaceutical industry profits.
The Health and Human Services Department, which is named as the defendant in the lawsuits, did not immediately respond to CNBC's request for comment.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Biden to host Israel’s Herzog amid tensions between two nationsPresident Biden's meeting with Israeli President Isaac Herzog comes as Biden has been critical of the leader of Israel’s ruling coalition, Prime Minister Benjamin Netanyahu.
Weiterlesen »
Marjorie Taylor Greene complains about 'socialist' MedicareThe GOP lawmaker spoke on Sunday about welfare programs that were introduced during the Biden and President Lyndon B. Johnson administrations.
Weiterlesen »
94.1 WIP host Jon Johnson back on the air after cancer scareJohnson said the skin cancer was on part of his scalp he never would've seen on his own.
Weiterlesen »
Annual Marcus Johnson Summer Jazz Camp begins in MobileThis will all lead up to a camp concert gala which will celebrate the festival’s 25 years of jazz music.
Weiterlesen »